Jijin Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jijin Yang

Showing results (41-50 of 46) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 46 results.

Journal of Interventional Medicine|November 22, 2021

Shanghai expert consensus on totally implantable access ports 2019Xiaoyi Ding, Fang Ding, Yonggang Wang, et al.

Hepatology (Baltimore, Md.)|February 14, 2015

The role of hepatic resection in the treatment of hepatocellular cancerSasan Roayaie, Ghalib Jibara, Parissa Tabrizian, et al.

BMC Cancer|March 4, 2018

Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON studySheng-Long Ye, Jiamei Yang, Ping Bie, et al.

Oncotarget|January 7, 2016

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON studySheng-Long Ye, Xiaoping Chen, Jiamei Yang, et al.

Hepatology (Baltimore, Md.)|July 5, 2014

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.

Journal of Cancer Research and Therapeutics|August 29, 2024

Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop reportBin Liu, Wei Huang, Fujun Zhang, et al.

Pageof 5

Search research articles

Showing results (41-50 of 46) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 46 results.

Journal of Interventional Medicine|November 22, 2021

Shanghai expert consensus on totally implantable access ports 2019Xiaoyi Ding, Fang Ding, Yonggang Wang, et al.

Hepatology (Baltimore, Md.)|February 14, 2015

The role of hepatic resection in the treatment of hepatocellular cancerSasan Roayaie, Ghalib Jibara, Parissa Tabrizian, et al.

BMC Cancer|March 4, 2018

Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON studySheng-Long Ye, Jiamei Yang, Ping Bie, et al.

Oncotarget|January 7, 2016

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON studySheng-Long Ye, Xiaoping Chen, Jiamei Yang, et al.

Hepatology (Baltimore, Md.)|July 5, 2014

Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trialMasatoshi Kudo, Guohong Han, Richard S Finn, et al.

Journal of Cancer Research and Therapeutics|August 29, 2024

Guidelines for permanent iodine-125 seed interstitial brachytherapy for pancreatic cancer (2023 edition): The Chinese expert consensus workshop reportBin Liu, Wei Huang, Fujun Zhang, et al.

Pageof 5